New 'Supercharged' immune cell therapy targets Tough-to-Treat melanoma
NCT ID NCT06708455
Summary
This study is testing a new cell therapy called RAPA-201 for people with advanced melanoma that has spread and has stopped responding to standard immunotherapy. Doctors will collect a patient's own immune cells, modify them in a lab to better fight cancer, and then infuse them back. The main goal is to see if this treatment can shrink tumors in patients who have run out of other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.